Ehrlichia and Anaplasma Species by PCR
Also known as: EHR ANAPCR
Use
This test is primarily used for the diagnosis of possible tick-borne diseases such as Anaplasmosis or Ehrlichiosis during the acute phase of the disease. PCR provides a rapid means for the qualitative detection and speciation of DNA from Anaplasma phagocytophilum, Ehrlichia chaffeensis, Ehrlichia ewingii/E. canis, and E. muris-like pathogens, aiding in timely diagnosis and patient management. However, it should be noted that E. ewingii and E. canis cannot be differentiated by this test.
Special Instructions
Not provided.
Limitations
A negative result does not exclude the presence of PCR inhibitors in the patient specimen or the presence of target DNA below the detectable level of the assay. Additionally, the test cannot differentiate between E. ewingii and E. canis if detected. As this is a Laboratory Developed Test, it has not been cleared or approved by the US Food and Drug Administration, but it is performed in a CLIA certified laboratory for clinical purposes.
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
LOINC Codes
- 30039-2 - A phagocytoph DNA Bld Ql NAA+probe
- 27994-3 - E chaffeensis DNA Bld Ql NAA+probe
- 48865-0 - E ewingii DNA Spec Ql NAA+probe
- 48866-8 - Ehrlichia DNA Spec Ql NAA+probe
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
1 mL
Minimum Volume
0.6 mL
Container
Lavender (EDTA) or Pink (K2EDTA)
Storage Instructions
Refrigerated
Causes for Rejection
Serum, plasma, and heparinized specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 1 week |
| Frozen | 1 week |
Other tests from different labs that may be relevant